UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease

Metabolism, clinical and experimental, 2015-09, Vol.64 (9), p.982-990

2015

Volltextzugriff (PDF)

Mechanism of Action of Niacin

The American journal of cardiology, 2008-04, Vol.101 (8), p.S20-S26

2008

Volltextzugriff (PDF)

Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells

Atherosclerosis, 2009-01, Vol.202 (1), p.68-75

2009

Volltextzugriff (PDF)

The mechanism and mitigation of niacin-induced flushing

International journal of clinical practice (Esher), 2009-09, Vol.63 (9), p.1369-1377

2009

Volltextzugriff (PDF)

Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease

American journal of physiology: Gastrointestinal and liver physiology, 2014-02, Vol.306 (4), p.G320-G327

2014

Volltextzugriff (PDF)

"Bottom‐up" in situ proteomic differentiation of human and non‐human haemoglobins for forensic purposes by matrix‐assisted laser desorption/ionization time‐of‐flight tandem mass spectrometry

Rapid communications in mass spectrometry, 2017-11, Vol.31 (22), p.1927-1937

2017

Volltextzugriff (PDF)

Niacin inhibits surface expression of ATP synthase β chain in HepG2 cells: implications for raising HDL

Journal of lipid research, 2008-06, Vol.49 (6), p.1195-1201

2008

Volltextzugriff (PDF)

Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells

Journal of lipid research, 2012-05, Vol.53 (5), p.941-950

2012

Volltextzugriff (PDF)

Niacin and cholesterol: role in cardiovascular disease (review)

The Journal of nutritional biochemistry, 2003-06, Vol.14 (6), p.298-305

2003

Volltextzugriff (PDF)

Nicotinic Acid (Niacin) Receptor Agonists: Will They Be Useful Therapeutic Agents?

The American journal of cardiology, 2007-12, Vol.100 (11), p.S53-S61

2007

Volltextzugriff (PDF)

Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells

Journal of lipid research, 2004-10, Vol.45 (10), p.1835-1845

2004

Volltextzugriff (PDF)

Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression

American journal of physiology: endocrinology and metabolism, 2000-07, Vol.279 (1), p.E11-E17

2000

Volltextzugriff (PDF)

Niacin increases human aortic endothelial Sirt1 activity and nitric oxide: effect on endothelial function and vascular aging

American journal of translational research, 2023, Vol.15 (12), p.6771-6778

2023

Volltextzugriff (PDF)

Niacin therapy in atherosclerosis

Current opinion in lipidology, 2004-12, Vol.15 (6), p.659-665

2004

Volltextzugriff (PDF)

Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells

Journal of lipid research, 2010-08, Vol.51 (8), p.2211-2222

2010

Volltextzugriff (PDF)

Niacin for treatment of nonalcoholic fatty liver disease (NAFLD): novel use for an old drug?

Journal of clinical lipidology, 2019-11, Vol.13 (6), p.873-879

2019

Volltextzugriff (PDF)

Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol

Arteriosclerosis, thrombosis, and vascular biology, 2001-11, Vol.21 (11), p.1783-1789

2001

Volltextzugriff (PDF)

Recent advances in niacin and lipid metabolism

Current opinion in lipidology, 2013-06, Vol.24 (3), p.239-245

2013

Volltextzugriff (PDF)

Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport

Arteriosclerosis, thrombosis, and vascular biology, 1997-10, Vol.17 (10), p.2020-2028

1997

Volltextzugriff (PDF)

Niacin regresses collagen content in human hepatic stellate cells from liver transplant donors with fibrotic non-alcoholic steatohepatitis (NASH)

American journal of translational research, 2022-01, Vol.14 (6), p.4006-4014

2022

Volltextzugriff (PDF)

Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells

Arteriosclerosis, thrombosis, and vascular biology, 1999-04, Vol.19 (4), p.1051-1059

1999

Volltextzugriff (PDF)

Low density lipoproteins transactivate EGF receptor: Role in mesangial cell proliferation

Life sciences (1973), 2008-10, Vol.83 (17), p.595-601

2008

Volltextzugriff (PDF)

Mechanism of action of niacin on lipoprotein metabolism

Current atherosclerosis reports, 2000, Vol.2 (1), p.36-46

2000

Volltextzugriff (PDF)

Niacin decreases leukocyte myeloperoxidase: Mechanistic role of redox agents and Src/p38MAP kinase

Atherosclerosis, 2014-08, Vol.235 (2), p.554-561

2014

Volltextzugriff (PDF)

Lysophosphatidylcholine stimulates EGF receptor activation and mesangial cell proliferation: Regulatory role of Src and PKC

Biochimica et biophysica acta, 2007-11, Vol.1771 (11), p.1364-1371

2007

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(144)

Publikationsform

Sprache

Englisch
(191)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease

Mechanism of Action of Niacin

Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells

The mechanism and mitigation of niacin-induced flushing

Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease

"Bottom‐up" in situ proteomic differentiation of human and non‐human haemoglobins for forensic purposes by matrix‐assisted laser desorption/ionization time‐of‐flight tandem mass spectrometry

Niacin inhibits surface expression of ATP synthase β chain in HepG2 cells: implications for raising HDL

Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells

Niacin and cholesterol: role in cardiovascular disease (review)

Nicotinic Acid (Niacin) Receptor Agonists: Will They Be Useful Therapeutic Agents?

Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells

Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression

Niacin increases human aortic endothelial Sirt1 activity and nitric oxide: effect on endothelial function and vascular aging

Niacin therapy in atherosclerosis

Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells

Niacin for treatment of nonalcoholic fatty liver disease (NAFLD): novel use for an old drug?

Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol

Recent advances in niacin and lipid metabolism

Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport

Niacin regresses collagen content in human hepatic stellate cells from liver transplant donors with fibrotic non-alcoholic steatohepatitis (NASH)

Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells

Low density lipoproteins transactivate EGF receptor: Role in mesangial cell proliferation

Mechanism of action of niacin on lipoprotein metabolism

Niacin decreases leukocyte myeloperoxidase: Mechanistic role of redox agents and Src/p38MAP kinase

Lysophosphatidylcholine stimulates EGF receptor activation and mesangial cell proliferation: Regulatory role of Src and PKC

Suchergebnisse filtern